Thymic myeloid cells are heterogenous and include a novel population of transitional dendritic cells. [PDF]
J Exp MedVobořil M +6 more
europepmc +1 more source
Cancer Immunotherapy via Disruption of Integrin αvβ3 and CD47 Costabilization on Cancer Cell Surface. [PDF]
Adv Sci (Weinh)Yu PC +12 more
europepmc +1 more source
Thymic Dendritic Cells Revisited. [PDF]
Immunol RevVobořil M, Xuan S, Hogquist KA.
europepmc +1 more source
Therapeutic Strategies Targeting Anti-CD47 Therapies in Glioblastoma Multiforme: Lead or Dead End? [PDF]
J Cell Mol MedBuliman A +4 more
europepmc +1 more source
Macrophage efferocytosis in cardiovascular disease: mechanisms and therapeutic implications. [PDF]
ImmunohorizonsGupta N, Liu Y, Cai B.
europepmc +1 more source
A CD47 antibody with minimized erythrocyte and thrombocyte toxicities. [PDF]
Front OncolPei M +13 more
europepmc +1 more source
Enhancing macrophage phagocytosis of cancers by disrupting the SIRPα/CD47 signaling axis and targeting MUC1 antigen. [PDF]
FEBS JMuneekaew S +5 more
europepmc +1 more source
Notch2-dependent DC2s mediate splenic germinal center responses [PDF]
, 2018 Bagadia, Prachi +9 more
core +1 more source
Roles of the phagocytosis checkpoint in radiotherapy. [PDF]
Cell Death DisKui Y, Tong F, Zhang R, Wang J, Dong X.
europepmc +1 more source
Targeting Myeloid Cells for Cancer Immunotherapy. [PDF]
Cancer Immunol ResBlanchard L, Mijacika A, Osorio JC.
europepmc +1 more source